FDA recall D-1056-2019
Allergan Sales, LLC · Class II · drug
Product
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05
Reason for recall
cGMP Deviations
Distribution
TN only
Key facts
- Status
- Terminated
- Initiation date
- 2019-03-19
- Report date
- 2019-04-03
- Termination date
- 2020-04-29
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Waco, TX, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1056-2019